VC Term Sheet

A VC term sheet is the document that starts substantive negotiation of a venture capital financing round. For a faculty founder or a university spinout’s early team, it is often the first legal document from an outside investor they will ever read, and it looks deceptively simple — typically two to five pages — compared to the fifty-plus-page definitive agreements it eventually leads to. That brevity is the point: a term sheet is meant to establish alignment on the handful of terms that actually determine how much control and economic upside the founders retain, before either side spends money on the legal work to draft binding documents.

What a term sheet is not

A VC term sheet is explicitly distinct from the university’s own licensing and equity paperwork. A technology transfer office (TTO) negotiates an exclusive license or option agreement with the spinout that sets royalty rates, sublicensing terms, and any equity stake the university itself takes in exchange for licensing the underlying intellectual property — this is a binding agreement between the university (licensor) and the company (licensee) over the technology itself. A VC term sheet, by contrast, is a non-binding proposal from an outside investor covering an equity investment in the company as a whole. See CASRAI’s guide on funding options for a university spinout for how licensing income, non-dilutive federal funding (SBIR/STTR), and outside VC fit together as a spinout matures — this entry goes one level deeper into what the VC term sheet itself actually contains once a spinout reaches that external-capital stage.

Most of a term sheet’s clauses are explicitly non-binding — the parties are not obligated to close the financing on the stated terms, and either side can walk away during due diligence. A small number of provisions are typically carved out as binding regardless: confidentiality, an exclusivity or “no-shop” clause preventing the company from soliciting competing offers for a set period, and governing law. Founders sometimes underestimate how binding the no-shop provision is in practice: it can take the company off the market for 30-60 days while the investor completes due diligence, with no guarantee the round actually closes.

Valuation: pre-money, post-money, and price per share

The term sheet states the round’s pre-money valuation (what the investor is valuing the company at before the new investment) and the post-money valuation (pre-money plus the new investment amount). Dividing the post-money valuation by the company’s fully diluted share count — including outstanding options, an unallocated option pool if the term sheet requires expanding one before the round, and any convertible instruments converting into the round — yields the price per share the new investor pays. Because the option pool is typically added to the pre-money valuation (an “option pool shuffle”), the effective price founders receive for their own shares is often lower than the headline pre-money number suggests; this is one of the more consequential negotiation points for founders and worth checking with counsel or the TTO’s own commercialization advisors rather than taking the headline valuation at face value.

Liquidation preference

A liquidation preference determines who gets paid first, and how much, if the company is sold, liquidated, or otherwise has an exit event. The investor’s preferred stock typically carries a preference multiple — most commonly 1x, meaning the investor is entitled to get its original investment back before common stockholders (including founders and, indirectly, the university’s own equity stake if it holds common stock) receive anything. Preferences above 1x (2x, 3x) exist but are less common in a standard early-stage round and are a signal worth flagging for negotiation. A separate question is whether the preference is participating (the investor takes its preference amount and then also shares in the remaining proceeds pro rata with common) or non-participating (the investor takes the greater of its preference or its as-converted common share, but not both) — non-participating is the more founder-favorable and more common structure in current market practice, including in the National Venture Capital Association’s (NVCA) widely used model term sheet.

Anti-dilution protection

Anti-dilution provisions protect the investor if the company later raises a “down round” — a subsequent financing at a lower price per share than the investor paid. Rather than a full ratchet (which would fully reprice the earlier investor’s shares to the new, lower price, heavily diluting founders and earlier investors), most current-market term sheets use a broad-based weighted-average formula, which adjusts the investor’s conversion price by a formula that accounts for both the size of the down round and the company’s total outstanding shares — a materially less punitive outcome for founders than a full ratchet, and the standard default in the NVCA model documents.

Board composition

The term sheet specifies how many board seats the investor gets and the overall board structure — commonly, for an early institutional round, something like a five-person board with two founder seats, one or two investor seats, and one or two independent seats the parties jointly agree on. Board composition determines who controls decisions the company’s charter or bylaws reserve to the board, including hiring and firing the CEO, approving future financings, and approving a sale of the company — board control is frequently as consequential to a founder as the economic terms, and often more so over the life of the company.

Pro-rata rights

Pro-rata rights (sometimes called preemptive rights) let an existing investor invest in a future financing round in an amount sufficient to maintain its current ownership percentage, rather than being diluted by new investors entering later rounds. The NVCA model term sheet typically extends this right to “major investors” — investors above a stated ownership or investment-size threshold — and some versions include a waterfall mechanism letting other major investors pick up any pro-rata allocation a given investor chooses not to exercise. For founders, pro-rata rights matter mainly at the next round: a large existing investor exercising its full pro-rata allocation can crowd out the amount of the new round available to a prospective new lead investor, which is worth understanding before agreeing to the right in the first place.

Other terms founders commonly see

Beyond the five terms above, a typical VC term sheet also addresses: a protective provisions clause listing company actions (issuing new stock, taking on debt above a threshold, amending the charter) that require investor consent; information rights requiring the company to share financial statements and a board package on a regular cadence; a drag-along provision that can compel minority stockholders, including founders, to vote in favor of a sale approved by a specified majority; and, less commonly at the earliest stage, a redemption right letting investors force the company to repurchase their shares after a set number of years if there has been no exit.

Why this matters for a university spinout specifically

A faculty founder negotiating a VC term sheet is doing so on top of, not instead of, the university’s own equity or royalty stake in the company from the underlying license — the university’s position (typically common stock, sometimes with anti-dilution protection of its own negotiated into the license agreement) is affected by the VC round’s terms even though the university is not a party to the term sheet negotiation itself. A liquidation preference stacked ahead of common stock, or a large new option pool created as part of the round, dilutes the university’s equity stake in the same proportion it dilutes the founders’. Institutions increasingly recommend that spinout founders retain their own counsel — separate from both the university’s TTO and any counsel the investor recommends — specifically because the TTO’s institutional interest in the license and the founder’s personal interest in the term sheet, while usually aligned, are not identical.

Frequently asked questions

Is a VC term sheet legally binding?

Not on the substantive deal terms. Most term sheets are non-binding except for a small set of carve-outs — typically confidentiality, exclusivity/no-shop, and governing law — that do bind the parties even before the definitive financing documents are signed.

What is the NVCA model term sheet?

It is a standardized, publicly available template published by the National Venture Capital Association (NVCA) that many US venture financings use as a starting point, so that founders and investors negotiate deviations from known, industry-standard default terms rather than drafting every provision from scratch.

How is a VC term sheet different from the university’s license agreement with the spinout?

The license or option agreement is a binding contract between the university (as licensor of the underlying IP) and the spinout (as licensee), covering royalties, sublicensing, and any equity the university takes for the license. The VC term sheet is a separate, non-binding proposal from an outside investor covering an equity investment in the company itself — the two documents govern different relationships and are negotiated with different counterparties.

What is the difference between participating and non-participating liquidation preference?

A participating preference lets the investor take its preference amount and then also share pro rata in the remaining exit proceeds with common stockholders. A non-participating preference (the more founder-favorable and currently more common structure) gives the investor the greater of its preference amount or its as-converted common share, but not both.